JLK,Inc. (KOSDAQ:322510)
South Korea · Delayed Price · Currency is KRW 6,530.00
-30.00 (-0.46%)
Jul 18, 2025, 3:30 PM KST
JLK,Inc. Company Description
JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea.
The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases.
The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology.
The company was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. is headquartered in Cheongju, South Korea.
JLK,Inc.
| Country | South Korea |
| Industry | Prepackaged Software |
| Employees | 71 |
| CEO | Dongmin Kim |
Contact Details
Address: 40, Yeongudanji-ro Cheongju South Korea | |
| Phone | 82 7 04651 4051 |
| Website | jlkgroup.com |
Stock Details
| Ticker Symbol | 322510 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Dongmin Kim | Chief Executive Officer |